Abbott
Abbott Receives European Regulatory Approval for New Ovarian Cancer Diagnostic Test
Published in Oncology Business Week, January 31st, 2010
A new diagnostic tool, which studies show can aid in determining the risk of whether a pelvic mass is benign or malignant, is now available in Europe. This simple blood test is expected to help in the assessment of epithelial ovarian cancer, the most lethal form of gynecological cancer. This important immunoassay, which will run on Abbott's ARCHITECT systems, is the first automated HE4 test available anywhere in the world.
Research has shown that this novel diagnostic marker, combined with other tests such as the CA125 assay, can aid in measuring the risk of epithelial ovarian cancer in pre- and post-menopausal women who have a pelvic mass.
According...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- 2Insure4Less.com
2Insure4Less.com's Free Online Comparison Service and iPhone App Help Consumers Start the New Year Right with Strategic Insurance Shopping - 4SC AG
4SC Announces First Patient Treated in a Phase II Hodgkin's Lymphoma Study with HDAC Inhibitor Resminostat 4SC-201 - A.P. Pharma, Inc.
A.P. Pharma Receives $2.5 Million Milestone Payment - Aasld
AASLD Applauds Landmark IOM Study That Shows the Path to Eradicate Hepatitis B and C - Advaxis, Inc.
Advaxis to Present at the Sidoti Microcap 2010 Investor Conference - Aetna and US Oncology, Inc.
Study of Evidence-Based Treatment for Lung Cancer Patients Shows Enhanced Value: Equivalent Outcomes and a 35 Percent Cost Savings - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
